Genetics | Penn Today

Gene therapy helps those with rare form of blindness see better at night

A clinical trial at the Scheie Eye Institute in the Perelman School of Medicine finds that an experimental gene therapy can rapidly improve night vision in adults with a congenital form of childhood-onset blindness, featuring a quote from Artur Cideciyan.

Integrating genetic testing orders into EHRs saves time, study says

A study from the Perelman School of Medicine suggests that time is saved when clinicians are able to order genetic testing through electronic health record systems.

University of Pennsylvania receives $55 million gift to study, treat hereditary cancers

The $55 million gift from alumni Mindy and Jon Gray will be used to establish the Basser Cancer Interception Institute, featuring a statement from President Liz Magill.

Understanding metabolism genes might improve depression treatment

David Oslin of the Perelman School of Medicine discusses the implications of his latest research examining whether genetic testing can be used to help prescribe antidepressants.

Solving medical mysteries with genetics: The Penn Neurogenetics Therapy Center

The Penn Neurogenetics Therapy Center works to achieve a genetic diagnosis for as many patients as possible, and establish clinical trials using novel gene and molecular therapies.

Kimyatta Frazier in scrubs standing in a hospital room.

Proactive genetic testing for hereditary cancer risk can help improve outcomes

Neonatal intensive care nurse Kimyatta Frazier found solace in a relationship with a genetic counselor at Penn Medicine who would be instrumental in helping her feel more in control of any future cancer diagnoses.

$25M gift establishes Armellino Center of Excellence for Williams Syndrome at Penn Medicine

The generosity of Penn alumnus Michael Armellino creates a center for the care of patients with the rare genetic condition across all stages of life and propels scientific discovery.

two DNA double helixes next to an illustration of the SARS-CoV-2 virus

Genomic differences selected through evolution may offer clues as to why COVID-19 outcomes vary widely

A team from the University of Pennsylvania analyzed genomic data from global populations, including thousands of ethnically diverse Africans, to identify genetic variants that may be associated with clinical COVID-19 outcomes.

Genomic differences selected through evolution may offer clues as to why COVID-19 outcomes vary widely

PIK Professor Sarah Tishkoff explains how her team’s studies use what happens in nature and signatures of natural selection to identify functionally important variants

Both nature and nurture contribute to signatures of socioeconomic status in the brain

Gideon Nave of the Wharton School and Martha Farah of the School of Arts & Sciences are quoted on their work that found evidence that both genetics and environmental influences contribute to the impact of socioeconomic status in a complex interplay with effects that span a variety of brain regions.

Filters

Gene therapy helps those with rare form of blindness see better at night

Integrating genetic testing orders into EHRs saves time, study says

University of Pennsylvania receives $55 million gift to study, treat hereditary cancers

Understanding metabolism genes might improve depression treatment

Solving medical mysteries with genetics: The Penn Neurogenetics Therapy Center

Proactive genetic testing for hereditary cancer risk can help improve outcomes

$25M gift establishes Armellino Center of Excellence for Williams Syndrome at Penn Medicine

Genomic differences selected through evolution may offer clues as to why COVID-19 outcomes vary widely

Genomic differences selected through evolution may offer clues as to why COVID-19 outcomes vary widely

Both nature and nurture contribute to signatures of socioeconomic status in the brain